ArticleCancer immunology, immunotherapy : CII2025

Neoantigen load as a predictor of relapse in early-stage NSCLC: features that agonise and antagonise prognosis.

Linda Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.